Pharmacokinetics and safety of insulin glulisine in children and adolescents with Type 1 diabetes

被引：0
|
作者：
Danne, T
Rave, K
Bittner, C
Heise, T
Frick, AD
Becker, RHA
机构：
[1] Bult Diabet Ctr Children & Adolescents, Hannover, Germany
[2] Profil Inst Metab Res, Neuss, Germany
[3] Aventis, Frankfurt, Germany
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
825
引用
收藏
页码：A297 / A298
页数：2
相关论文
共 50 条
  • [31] Individualized insulin therapy in children and adolescents with type 1 diabetes
    Becker, D
    ACTA PAEDIATRICA, 1998, 87 : 20 - 24
  • [32] The Efficacy of Insulin Degludec in Children and Adolescents with Type 1 Diabetes
    Bruzzi, Patrizia
    Maltoni, Giulio
    Predieri, Barbara
    Zucchini, Stefano
    Iughetti, Lorenzo
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 85 - 85
  • [33] Insulin glulisine: dose response relationship in subjects with type 1 diabetes
    Nosek, L.
    Becker, R. H. A.
    Frick, A. D.
    Heinemann, L.
    Rave, K.
    DIABETOLOGIA, 2006, 49 : 621 - 621
  • [34] Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes
    Robertson, K. J.
    Schoenle, E.
    Gucev, Z.
    Mordhorst, L.
    Gall, M. -A.
    Ludvigsson, J.
    DIABETIC MEDICINE, 2007, 24 (01) : 27 - 34
  • [35] Efficacy and Safety of Degludec in Children and Adolescents with Type 1 Diabetes
    Iughetti, Lorenzo
    Bruzzi, Patrizia
    Maltoni, Giulio
    Zucchini, Stefano
    Graziani, Vanna
    Suprani, Tosca
    Predieri, Barbara
    DIABETES, 2017, 66 : A382 - A382
  • [36] Comparison of the pharmacodynamics and pharmacokinetics of bolus subcutaneous insulin glulisine and insulin lispro in obese patients with type 2 diabetes
    Luzio, SD
    Peter, R
    Dunseath, GJ
    Mustafa, N
    Owens, DR
    DIABETOLOGIA, 2005, 48 : A307 - A307
  • [37] Evaluation of Efficacy, Safety and QOL of Glulisine on Japanese Type 1 Diabetes
    Yanagisawa, Katsuyuki
    Yamagishi, Sho-Ichi
    Ashihara, Jun-Ya
    Obara, Shinji
    Wada, Norio
    DIABETES, 2013, 62 : A654 - A654
  • [38] Efficacy and safety of a fixed combination of insulin degludec/insulin aspart in children and adolescents with type 1 diabetes: A randomized trial
    Battelino, Tadej
    Deeb, Larry C.
    Ekelund, Magnus
    Kinduryte, Ona
    Klingensmith, Georgeanna J.
    Kocova, Mirjana
    Kovarenko, Margarita
    Shehadeh, Naim
    PEDIATRIC DIABETES, 2018, 19 (07) : 1263 - 1270
  • [39] The Safety and Efficacy of Virtual Insulin Pump Initiation in Children and Adolescents with Type 1 Diabetes in the United States
    Pellizzari, Margaret
    Nwosu, Benjamin U.
    Pavlovic, Maia
    Talib, Rashida
    Sohail, Rubab
    Ciron, Jason
    DIABETES, 2024, 73
  • [40] Pharmacodynamics (PD) and pharmacokinetics (PK) of insulin glulisine (GLU) versus insulin lispro (IL) and regular human insulin (RHI) in patients with type 1 diabetes
    Burger, F
    Scholtz, H
    Frick, A
    Becker, RHA
    DIABETES, 2004, 53 : A557 - A557
12345